AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33940380 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanostomy tube placement at or before 8 weeks of age
Number of subjects: 22
Study 35766053 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1875% ropivacaine
Number of subjects: 50
Study 35766053 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine
Number of subjects: 50
Study 33685850 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucosamine, chondroitin sulfate, and methylsulfonylmethane (GCM) supplementation after arthrocentesis plus intraarticular hyaluronic acid (HA) injection
Number of subjects: 26
Study 33685850 — intervention group
Group type: COMPARATOR
Intervention: Control group: Arthrocentesis plus intraarticular HA injection only
Number of subjects: 26
Study 33980536 — intervention group
Group type: EXPERIMENTAL
Intervention: Community follow-up by non-medical practitioners
Number of subjects: 742
Study 33980536 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based secondary care
Number of subjects: 742
Study 35895571 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal aerobic and strength exercises programs (6 weeks of supervised intermittent aerobic cycling, home‐based walking, isometric and electrical muscle stimulation (EMS) exercise training)
Number of subjects: 32
Study 35895571 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study 34814738 — intervention group
Group type: EXPERIMENTAL
Intervention: PROMISE intervention
Number of subjects: 12000
Study 35487751 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 weeks of Frame Running training two times weekly for 60 min
Number of subjects: 62
Study 35487751 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 62
Study 34005909 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulation point probabilities in complex networks
Number of subjects: 0
Study 34005909 — intervention group
Group type: EXPERIMENTAL
Intervention: Bredge probabilities in complex networks
Number of subjects: 0
Study 34489161 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus concurrent chemoradiotherapy (cCRT) followed by nivolumab with ipilimumab (Arm A)
Number of subjects: 0
Study 34489161 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab alone (Arm B)
Number of subjects: 0
Study 34489161 — intervention group
Group type: COMPARATOR
Intervention: Concurrent chemoradiotherapy followed by durvalumab (Arm C)
Number of subjects: 0
Study 33303397 — intervention group
Group type: EXPERIMENTAL
Intervention: AL method
Number of subjects: 32
Study 33973655 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/kg intravenous dose of raxibacumab over a period of 2.25 hours
Number of subjects: 322
Study 32886915 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP) placement
Number of subjects: 1096
Study 32886915 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive intra-arterial endovascular treatment for vasospasm
Number of subjects: 1096
Study 32886915 — intervention group
Group type: COMPARATOR
Intervention: Non-aggressive treatment for vasospasm
Number of subjects: 1096
Study 35750735 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app clinical decision support tools (CDST)
Number of subjects: 0
Study 35750735 — intervention group
Group type: EXPERIMENTAL
Intervention: Print CDST
Number of subjects: 0
Study 35750735 — intervention group
Group type: COMPARATOR
Intervention: No CDST
Number of subjects: 0
Study 34343327 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Pain Threshold (PPT) over the median nerve
Number of subjects: 120
Study 34343327 — intervention group
Group type: EXPERIMENTAL
Intervention: Function
Number of subjects: 120
Study 34343327 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Pain Threshold (PPT) over the carpal tunnel
Number of subjects: 120
Study 34343327 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Pain Threshold (PPT) over the tibialis anterior
Number of subjects: 120
Study 33127291 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory muscle training (RMT)
Number of subjects: 22
Study 33127291 — intervention group
Group type: COMPARATOR
Intervention: Sham-RMT
Number of subjects: 22
Study 35191289 — intervention group
Group type: EXPERIMENTAL
Intervention: RST with CoD (n = 10)
Number of subjects: 20
Study 35191289 — intervention group
Group type: COMPARATOR
Intervention: RST without CoD (n = 10)
Number of subjects: 20
Study 33744640 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole grain consumption (50% of grain servings from whole grain foods daily for 6 weeks)
Number of subjects: 44
Study 35610353 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Water Dance Intervention (SWAN), administered for 40 min once a week during a 12-week period.
Number of subjects: 34
Study 33106354 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous faecal microbiota transplantation (FMT)
Number of subjects: 20
Study 33106354 — intervention group
Group type: COMPARATOR
Intervention: Healthy donor faecal microbiota transplantation (FMT)
Number of subjects: 20
Study 36145157 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (1600 IU/day)
Number of subjects: 154
Study 36145157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 34589204 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin-type fructans (16 g/d)
Number of subjects: 35
Study 34589204 — intervention group
Group type: COMPARATOR
Intervention: Control (maltodextrin)
Number of subjects: 35
Study 36034299 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Hz rTMS stimulation to the affected mylohyoid cortical region
Number of subjects: 49
Study 36034299 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 49
Study 36034299 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Hz rTMS
Number of subjects: 49
Study 36034299 — intervention group
Group type: EXPERIMENTAL
Intervention: Right rTMS
Number of subjects: 49
Study 33345430 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufficient 25(OH)D levels (<20 ng/mL)
Number of subjects: 422
Study 33345430 — intervention group
Group type: EXPERIMENTAL
Intervention: Relatively insufficient 25(OH)D levels (20–<30 ng/mL)
Number of subjects: 422
Study 33345430 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufficient 25(OH)D levels (≥30 ng/mL)
Number of subjects: 422
Study 36217795 — intervention group
Group type: EXPERIMENTAL
Intervention: D. esculenta (300 mg/day)
Number of subjects: 10
Study 36217795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 36055877 — intervention group
Group type: EXPERIMENTAL
Intervention: Pfizer mRNA COVID-19 vaccine
Number of subjects: 2
Study 36055877 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderna mRNA COVID-19 vaccine
Number of subjects: 2
Study 36055877 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined mRNA vaccines (Pfizer and Moderna)
Number of subjects: 2
Study 33831046 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab 400 mg
Number of subjects: 107
Study 34344266 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy during Nonstress Test
Number of subjects: 100
Study 34344266 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 100
Study 33119467 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of fluconazole (EDHF inhibition)
Number of subjects: 18
Study 33119467 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg of aspirin (prostaglandin inhibition)
Number of subjects: 18
Study 33119467 — intervention group
Group type: COMPARATOR
Intervention: maltodextrin (control)
Number of subjects: 18
Study 32841825 — intervention group
Group type: EXPERIMENTAL
Intervention: CrossFit Kids (CFK) program
Number of subjects: 144
Study 32841825 — intervention group
Group type: COMPARATOR
Intervention: PE class
Number of subjects: 144
Study 36180816 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispersible Pretomanid Tablets (DTF) 10 mg, 50 mg, 200 mg
Number of subjects: 48
Study 36180816 — intervention group
Group type: COMPARATOR
Intervention: Marketed Formulation (MF) 200 mg
Number of subjects: 48
Study 34786998 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model based on total prostate-specific antigen, clinical tumor stage, Gleason score, prostate volume, red cell distribution width, and serum alkaline phosphatase.
Number of subjects: 332
Study 32403062 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive appearance comment
Number of subjects: 192
Study 32403062 — intervention group
Group type: EXPERIMENTAL
Intervention: Reality check comment plus positive appearance comment
Number of subjects: 192
Study 32403062 — intervention group
Group type: COMPARATOR
Intervention: No comment
Number of subjects: 192
Study 33516927 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (IM) oral spray
Number of subjects: 60
Study 33516927 — intervention group
Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 60
Study 34454563 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based educational intervention for general practitioners
Number of subjects: 120
Study 32855160 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time continuous glucose monitoring (RT-CGM) with Dexcom G6
Number of subjects: 110
Study 32855160 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 110
Study 33156414 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise
Number of subjects: 24
Study 33156414 — intervention group
Group type: COMPARATOR
Intervention: Concentric exercise
Number of subjects: 24
Study 35236061 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial magnet therapy (TMT)
Number of subjects: 50
Study 35236061 — intervention group
Group type: COMPARATOR
Intervention: Low-frequency magnet therapy
Number of subjects: 50
Study 33709991 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-derived tumor organoid culture model
Number of subjects: 71
Study 32898990 — intervention group
Group type: EXPERIMENTAL
Intervention: Educated group (nurses with enhanced education)
Number of subjects: 190
Study 32898990 — intervention group
Group type: COMPARATOR
Intervention: Control group (nurses without enhanced education)
Number of subjects: 190
Study 32898990 — intervention group
Group type: EXPERIMENTAL
Intervention: Educated group
Number of subjects: 190
Study 35069808 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI
Number of subjects: 172
Study 35069808 — intervention group
Group type: COMPARATOR
Intervention: irinotecan
Number of subjects: 172
Study 33470748 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal cord stimulation (SCS)
Number of subjects: 0
Study 33470748 — intervention group
Group type: COMPARATOR
Intervention: Placebo/sham controls
Number of subjects: 0
Study 33470748 — intervention group
Group type: EXPERIMENTAL
Intervention: SCS-specific safety outcomes
Number of subjects: 0
Study 33508780 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric-overload training
Number of subjects: 56
Study 33508780 — intervention group
Group type: EXPERIMENTAL
Intervention: All training groups (except in-water-specific strength training)
Number of subjects: 56
Study 33508780 — intervention group
Group type: EXPERIMENTAL
Intervention: All training groups
Number of subjects: 56
Study 33508780 — intervention group
Group type: EXPERIMENTAL
Intervention: All training groups (except dry-land strength training)
Number of subjects: 56
Study 33508780 — intervention group
Group type: EXPERIMENTAL
Intervention: All training groups (except in-water-specific strength training and ballistic training)
Number of subjects: 56
Study 36273491 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD1222 (ChAdOx1 nCoV-19) vaccine
Number of subjects: 185
Study 34412797 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 758
Study 34412797 — intervention group
Group type: COMPARATOR
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 758
Study 32462773 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide (400 mg)
Number of subjects: 24
Study 32462773 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 35419078 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 39
Study 35419078 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupuncture treatment)
Number of subjects: 39
Study 33555830 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive (OC) users
Number of subjects: 21
Study 35419610 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation under anesthesia (MUA)
Number of subjects: 391
Study 35419610 — intervention group
Group type: COMPARATOR
Intervention: No MUA
Number of subjects: 391
Study 35513795 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-25(OH)D-Calcitriol group (calcitriol 0.25 µg bid)
Number of subjects: 30
Study 35513795 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-25(OH)D-Calcitriol group
Number of subjects: 30
Study 35513795 — intervention group
Group type: COMPARATOR
Intervention: Low-25(OH)D group
Number of subjects: 30
Study 35513795 — intervention group
Group type: COMPARATOR
Intervention: Low-25(OH)D-Calcitriol group and Normal-25(OH)D group
Number of subjects: 30
Study 32852352 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACYW-TT
Number of subjects: 1000
Study 32852352 — intervention group
Group type: COMPARATOR
Intervention: MenACWY-CRM
Number of subjects: 1000
Study 35316080 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine (1,250 mg/m2 twice daily on days 1‐14 of a 21‐day cycle, for eight cycles)
Number of subjects: 447
Study 35316080 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 447
Study 35316080 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine (adjusted for minimization factors, nodal status, grade, and sex)
Number of subjects: 447
Study 616664553 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual-Scanning Training (VST)
Number of subjects: 20
Study 616664553 — intervention group
Group type: EXPERIMENTAL
Intervention: Prismatic Adaptation (PA)
Number of subjects: 20
Study 616664553 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 20
Study 34651477 — intervention group
Group type: EXPERIMENTAL
Intervention: RATKA group (robot-assisted TKA using YUANHUA-TKA system)
Number of subjects: 60
Study 34651477 — intervention group
Group type: COMPARATOR
Intervention: Traditional TKA group
Number of subjects: 60
Study 34651477 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (RATKA and traditional TKA)
Number of subjects: 60
Study 34651477 — intervention group
Group type: EXPERIMENTAL
Intervention: RATKA group
Number of subjects: 60
Study 36208548 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT), 40 daily sessions
Number of subjects: 73
Study 36208548 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 73
Study 33556104 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom-catheter uterine balloon tamponade (UBT)
Number of subjects: 2246
Study 33556104 — intervention group
Group type: COMPARATOR
Intervention: No UBT
Number of subjects: 2246
Study 33556104 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall care satisfaction
Number of subjects: 2246
Study 33556104 — intervention group
Group type: EXPERIMENTAL
Intervention: Care aspects liked least
Number of subjects: 2246
Study 33307554 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity inspiratory muscle training at 80% of maximal inspiratory pressure, 3 sets of 12 repetitions
Number of subjects: 0
Study 33307554 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity inspiratory muscle training at 50% of maximal inspiratory pressure, 2 sets of 20 repetitions
Number of subjects: 0
Study 33307554 — intervention group
Group type: COMPARATOR
Intervention: Control group (no inspiratory muscle training)
Number of subjects: 0
Study 32441658 — intervention group
Group type: EXPERIMENTAL
Intervention: Do CHANGE intervention (3-month behavioral program with ecological momentary assessment and intervention technologies)
Number of subjects: 149
Study 32441658 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 149
Study 32441658 — intervention group
Group type: EXPERIMENTAL
Intervention: Do CHANGE intervention
Number of subjects: 149
Study 36064261 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified Culture System (SCS)
Number of subjects: 653
Study 36064261 — intervention group
Group type: COMPARATOR
Intervention: Intracytoplasmic Sperm Injection (ICSI)
Number of subjects: 653
Study 32798096 — intervention group
Group type: EXPERIMENTAL
Intervention: Texting their friend
Number of subjects: 130
Study 32798096 — intervention group
Group type: COMPARATOR
Intervention: No activity condition
Number of subjects: 130
Study 32798096 — intervention group
Group type: COMPARATOR
Intervention: Passive-phone condition
Number of subjects: 130
Study 35944412 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive (OC) users
Number of subjects: 27
Study 35944412 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 27
Study 35944412 — intervention group
Group type: EXPERIMENTAL
Intervention: Temperature at 40 °C
Number of subjects: 27
Study 35944412 — intervention group
Group type: COMPARATOR
Intervention: Menstrual cycle (MC)
Number of subjects: 27
Study 34468701 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Gastrectomy (LG)
Number of subjects: 241
Study 34468701 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic Gastrectomy (RG)
Number of subjects: 241
Study 35394687 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulina (5.7 g day-1)
Number of subjects: 17
Study 35394687 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isoproteic and caloric)
Number of subjects: 17
Study 33835329 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONS) 400ml (400kcal) per day for 12 weeks
Number of subjects: 1003
Study 33835329 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular diet)
Number of subjects: 1003
Study 33835329 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplements (ONS) for patients taking more than 200ml/day
Number of subjects: 1003
Study 32780315 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L
Number of subjects: 1200
Study 32780315 — intervention group
Group type: COMPARATOR
Intervention: EQ-5D-3L
Number of subjects: 1200
Study 32780315 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-5L and EQ-5D-3L
Number of subjects: 1200
Study 34351576 — intervention group
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 3032
Study 34351576 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic sleeve gastrectomy (LSG)
Number of subjects: 3032
Study 32054669 — intervention group
Group type: EXPERIMENTAL
Intervention: ApoCIII-Lp(a) complexes
Number of subjects: 218
Study 32054669 — intervention group
Group type: EXPERIMENTAL
Intervention: OxPL-apoB and OxPL-apo(a)
Number of subjects: 218
Study 32054669 — intervention group
Group type: COMPARATOR
Intervention: Autotaxin (ATX) on ApoB and ATX on Lp(a)
Number of subjects: 218
Study 35171199 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased adjusted NT-proBNP levels at year 1
Number of subjects: 1644
Study 35171199 — intervention group
Group type: COMPARATOR
Intervention: Normal NT-proBNP levels at year 1
Number of subjects: 1644
Study 34814585 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 μg hepatitis B vaccine
Number of subjects: 249
Study 34814585 — intervention group
Group type: COMPARATOR
Intervention: 20 μg hepatitis B vaccine
Number of subjects: 249
Study 33176308 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher prestroke Physical Activity (PA) as measured by the Physical Activity Scale for the Elderly (PASE) in quartiles (2nd, 3rd, and 4th)
Number of subjects: 625
Study 33176308 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher prestroke PA (quartiles 2nd, 3rd, and 4th)
Number of subjects: 625
Study 36436613 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen
Number of subjects: 90
Study 36436613 — intervention group
Group type: COMPARATOR
Intervention: Ambient air
Number of subjects: 90
Study 32597821 — intervention group
Group type: EXPERIMENTAL
Intervention: Social security hospitals
Number of subjects: 938
Study 32597821 — intervention group
Group type: COMPARATOR
Intervention: Private hospitals
Number of subjects: 938
Study 32597821 — intervention group
Group type: COMPARATOR
Intervention: Public hospitals
Number of subjects: 938
Study 32597821 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood management
Number of subjects: 938
Study 32597821 — intervention group
Group type: EXPERIMENTAL
Intervention: Safe drug management, error management, infection control, safe clinical services
Number of subjects: 938
Study 32597821 — intervention group
Group type: EXPERIMENTAL
Intervention: Management and leadership of patient safety
Number of subjects: 938
Study 32449452 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention
Number of subjects: 111
Study 32940428 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine (TM) service based on mobile health (mHealth), including remote daily monitoring of biometric data and symptom reporting combined with videoconference structured, nurse-based follow-up.
Number of subjects: 508
Study 32940428 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) strategy based on face-to-face on-site visits.
Number of subjects: 508
Study 35618364 — intervention group
Group type: EXPERIMENTAL
Intervention: Rock & Water social emotional learning intervention
Number of subjects: 1299
Study 34211390 — intervention group
Group type: EXPERIMENTAL
Intervention: Model-Based Working Memory Training with distractor inhibition (MB+)
Number of subjects: 123
Study 34211390 — intervention group
Group type: EXPERIMENTAL
Intervention: Model-Based Working Memory Training without distractor inhibition (MB)
Number of subjects: 123
Study 34211390 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual n-back training
Number of subjects: 123
Study 34211390 — intervention group
Group type: COMPARATOR
Intervention: Active control training
Number of subjects: 123
Study 33565339 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial hair implantation using biocompatible fibers (Biofibre®, Nido Z‐type)
Number of subjects: 0
Study 33565339 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 34065698 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality-Based Cognitive Stimulation (10 sessions over 2 months, 2 sessions/week)
Number of subjects: 17